Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Anish Bhatnagar
Relationship:  
City:   Redwood City
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   152,790    

Indirect Shares

  0      
Direct Value   $24,508    

Indirect Value

  $0      
Total Shares   152,790      
Total Value   $24,508      


Soleno Therapeutics Inc
 $24,508 Soleno Therapeutics Inc
 $24,508
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -100.0%
 -100.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Soleno Therapeutics Inc SLNO 2024-04-01 152,790 2015-08-12 0    Premium*  
* Premium Members only  

Records found :    18         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SLNO Soleno Therapeutics Inc CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-01 4 S $41.12 $784,645 D/D (18,980) 152,790 0 -
SLNO Soleno Therapeutics Inc CHIEF EXECUTIVE OFFICER   •       •      –    2024-01-25 4 S $48.30 $122,054 D/D (2,527) 171,770 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2024-01-04 4 A $0.00 $0 D/D 150,000 174,297 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-11 4 S $35.26 $3,331,701 D/D (93,408) 24,297 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2023-11-30 4 S $28.65 $794,116 D/D (27,716) 108,062 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2023-11-29 4 S $27.43 $774,535 D/D (27,827) 135,778 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2023-11-28 4 S $27.03 $696,514 D/D (25,678) 163,605 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2023-10-20 4 OE $1.75 $30,500 D/D 9,643 198,926 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2023-05-26 4 A $0.00 $0 D/D 160,602 189,283 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       •      –    2022-03-31 4 B $0.00 $0 D/D 60,000 430,227 2.73 %
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       –      –    2022-01-21 4 S $0.37 $14,559 D/D (39,033) 370,227 0 %
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       –      –    2021-01-23 4/A D $2.11 $76,631 D/D (36,318) 409,260 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       –      –    2021-01-23 4 D $2.11 $76,631 D/D (36,318) 4,060,780 0 -
SLNO Soleno Therapeutics Inc Chief Executive Officer   •       –      –    2020-01-23 4 A $3.35 $1,276,350 D/D 381,000 381,000 0 -
SLNO Soleno Therapeutics Inc See Remarks   •       •      –    2016-08-19 4 B $0.96 $9,600 D/D 10,000 83,419 2.81 -
SLNO Soleno Therapeutics Inc President and CEO   •       •      –    2016-05-13 4 B $1.15 $5,745 D/D 5,000 73,419 2.81 -
SLNO Soleno Therapeutics Inc President and CEO   •       •      –    2016-04-08 4 OE $1.20 $70,103 D/D 58,419 58,419 0 -
SLNO Soleno Therapeutics Inc See Remarks   •       •      –    2015-08-12 4 B $1.64 $16,400 D/D 10,000 10,000 2.81 -

  18  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed